Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Arrhythmias: A Network Meta-Analysis
Heart rhythm, 2026
UBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with type 2 diabetes: A multicenter, randomized phase 2 trial
Cell metabolism, 2026
Paracrine TMSB4X signaling from oligodendrocytes promotes diffuse glioma dissemination
Oncogene, 2026
Neuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity
Rambam Maimonides medical journal, 2026;17(4)
Impact of Semaglutide Introduction on the Use of Concomitant Medications: An Interrupted Time Series
Diabetes, obesity & metabolism, 2026
[Expert Council resolution: adjunctive pharmacotherapy for hyperkinetic disorders (attention deficit hyperactivity disorder) in children and adolescents]
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova;126(9. Vyp. 2):126-135
Semaglutide and Tirzepatide Suppress Hepatic Fatty Acid Uptake and Fatty Acid β-Oxidation in High-Fat Diet-Induced Obesity Mice
Journal of proteome research;25(10):5418-5429
Efficacy and safety of GLP-1 receptor agonists for antipsychotic-related overweight and metabolic dysregulation: a systematic review and meta-analysis
European journal of clinical pharmacology, 2026;82(11)
Parasympathetic dysfunction assessed by deep-breathing CVR-R is associated with early discontinuation of oral semaglutide in type 2 diabetes: A multicenter retrospective study
Journal of diabetes investigation, 2026
Butyrate enhances the obesity reduction effect of Semaglutide
Neuroendocrinology, 2026;:1
SEMAGLUTIDE TREATMENT IN TWO VERY YOUNG CHILDREN WITH SEVERE EARLY-ONSET OBESITY
Hormone research in paediatrics, 2026;:1
Skeletal effects of GLP-1 receptor agonist therapy in adults with overweight or obesity: a systematic review
Archives of osteoporosis, 2026;21(1)
Gut-brain axis in Alzheimer’s disease: neuroinflammatory mechanisms and immunopharmacological interventions
Inflammopharmacology, 2026
GLP-1-based therapies in cardiovascular disease: outcomes, mechanisms, and emerging clinical applications
European journal of clinical pharmacology, 2026;82(11)
Pharmacotherapy for MASLD: current evidence and challenges in clinical practice
Annals of hepatology, 2026;:102477
A rare diagnosis during evaluation for metabolic dysfunction associated steatotic liver disease: Glycogen storage disease type Ia presenting during adolescence in a male with severe obesity
JPGN reports, 2026
The Impact of Incretin-Based Therapies on Anthropometric and Metabolic Parameters in Women with Polyendocrine Metabolic Ovarian Syndrome
Diabetes, metabolic syndrome and obesity : targets and therapy, 2026;19:620819
Pancreatic and Gallbladder Adverse Events Associated with Tirzepatide in Obesity Management: A Scoping Review
Diabetes, metabolic syndrome and obesity : targets and therapy, 2026;19:637243
Modern antidiabetic therapy in older adults with type 2 diabetes: evidence, best practice and a clinical pharmacist’s framework
Expert review of clinical pharmacology, 2026
Transient Adipose Inflammatory Remodeling during High-Dose Semaglutide-Induced Weight Loss and Regain
Endocrinology and metabolism (Seoul, Korea), 2026